Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Matthews

Showing results (441-450 of 464) with videos related to

Pageof 47
Sort By:
Physical Chemistry Chemical Physics : PCCP|November 16, 2017
NEXAFS spectroscopy of ionic liquids: experiments versus calculationsRichard M Fogarty, Richard P Matthews, Matthew T Clough, et al.
Journal of Medicinal Chemistry|October 23, 2012
Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitorsMichael Lainchbury, Thomas P Matthews, Tatiana McHardy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2026
Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults Living With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From Two Open-Label, Phase 1 StudiesRuss P Carstens, Yash Kapoor, Ryan C Vargo, et al.
Leukemia & Lymphoma|September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)R M Lowenthal, K F Bradstock, J P Matthews, et al.
ACS Medicinal Chemistry Letters|October 15, 2014
Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic AneurysmPrabhakar K Jadhav, Matthew A Schiffler, Kostas Gavardinas, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2006
Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligandsAlan M Warshawsky, Charles A Alt, Joseph T Brozinick, et al.
British Journal of Haematology|June 19, 2001
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemiaJ P Matthews, J F Bishop, G A Young, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Potent benzimidazolone based human beta(3)-adrenergic receptor agonistsDon R Finley, Michael G Bell, Anthony G Borel, et al.
Scientific Reports|October 7, 2016
A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoformsAlan M Jones, Isaac M Westwood, James D Osborne, et al.
Cancer Research|March 3, 2007
In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitorsSwee Y Sharp, Kathy Boxall, Martin Rowlands, et al.
Pageof 47

Showing results (441-450 of 464) with videos related to

Sort By:
Pageof 47
Physical Chemistry Chemical Physics : PCCP|November 16, 2017
NEXAFS spectroscopy of ionic liquids: experiments versus calculationsRichard M Fogarty, Richard P Matthews, Matthew T Clough, et al.
Journal of Medicinal Chemistry|October 23, 2012
Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitorsMichael Lainchbury, Thomas P Matthews, Tatiana McHardy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2026
Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults Living With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From Two Open-Label, Phase 1 StudiesRuss P Carstens, Yash Kapoor, Ryan C Vargo, et al.
Leukemia & Lymphoma|September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)R M Lowenthal, K F Bradstock, J P Matthews, et al.
ACS Medicinal Chemistry Letters|October 15, 2014
Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic AneurysmPrabhakar K Jadhav, Matthew A Schiffler, Kostas Gavardinas, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2006
Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligandsAlan M Warshawsky, Charles A Alt, Joseph T Brozinick, et al.
British Journal of Haematology|June 19, 2001
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemiaJ P Matthews, J F Bishop, G A Young, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Potent benzimidazolone based human beta(3)-adrenergic receptor agonistsDon R Finley, Michael G Bell, Anthony G Borel, et al.
Scientific Reports|October 7, 2016
A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoformsAlan M Jones, Isaac M Westwood, James D Osborne, et al.
Cancer Research|March 3, 2007
In vitro biological characterization of a novel, synthetic diaryl pyrazole resorcinol class of heat shock protein 90 inhibitorsSwee Y Sharp, Kathy Boxall, Martin Rowlands, et al.
Pageof 47